Gene therapy for cardiovascular manifestations of lysosomal storage diseases.

about

Gene therapy for cardiovascular manifestations of lysosomal storage diseases.

Item

http://www.wikidata.org/entity/Q36631583

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Gene therapy for cardiovascular manifestations of lysosomal storage diseases.

@ast

Gene therapy for cardiovascular manifestations of lysosomal storage diseases.

@en

type

Item

label

Gene therapy for cardiovascular manifestations of lysosomal storage diseases.

@ast

Gene therapy for cardiovascular manifestations of lysosomal storage diseases.

@en

prefLabel

Gene therapy for cardiovascular manifestations of lysosomal storage diseases.

@ast

Gene therapy for cardiovascular manifestations of lysosomal storage diseases.

@en

P1476

Gene therapy for cardiovascular manifestations of lysosomal storage diseases.

@en

P2093

Katherine P Ponder

http://www.w3.org/2001/XMLSchema#string

Mark E Haskins

http://www.w3.org/2001/XMLSchema#string

Meg M Sleeper

http://www.w3.org/2001/XMLSchema#string

P2860

Gene therapy for mucopolysaccharidosis

Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon-mediated gene delivery: implications for non-viral gene therapy of mucopolysaccharidoses

Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs.

Cardiac manifestations in the mouse model of mucopolysaccharidosis I.

Correction of the biochemical and functional deficits in fabry mice following AAV8-mediated hepatic expression of alpha-galactosidase A.

Gene therapy for lysosomal storage diseases: the lessons and promise of animal models.

Cardiovascular manifestations of Fabry disease and the novel therapeutic strategies.

Pompe disease: current state of treatment modalities and animal models.

Upregulation of elastase proteins results in aortic dilatation in mucopolysaccharidosis I mice.

Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapy.

P304

21-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26937225

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

4771418

http://www.w3.org/2001/XMLSchema#string